Atlas FDA

EMIT METHATREXATE ASSAY

FDA 510(k) clearance K781381 · decided 1978-10-10

Clearance details

K-number
K781381
Device name
EMIT METHATREXATE ASSAY
Applicant
Dade Behring, Inc.
Decision
Substantially Equivalent
Date received
1978-08-11
Decision date
1978-10-10
Days to decision
60 days
Clearance type
Traditional
Product code
LAO
Device class
U
Medical specialty
Unknown
Advisory committee
Unknown
Location
Newark, DE, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Dade Behring

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
ONLINE TDM Methotrexate (K233454)Roche Diagnostics Operations2024-02-20
ARK Methotrexate II Assay (K232017)Ark Diagnostics, Inc.2023-12-20
ARK Methotrexate Assay (K163359)Ark Diagnostics, Inc.2017-08-18
ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK METHOTREXATE CONTROL, ARK METHOTREXATE CONTROL (CALIBRATION RAN (K111904)Ark Diagnostics, Inc.2011-10-18
TDX(R)/TDX(R)FLX(R)MEHTOTREXATE II (K932615)Abbott Laboratories1993-07-14
ACA DU PONT METHOTREXATE (MTHO) METHOD (K884744)E.I. Dupont DE Nemours & Co., Inc.1989-01-30
EMIT & METHOFREXATE ASSAY (K833634)Syva Co.1983-12-22
TDX METHOTREXATE (K830398)Abbott Laboratories1983-03-10
EMIT-AND METHOTREXATE ASSAY (K811459)Syva Co.1981-06-09

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
COBAS INTEGRA 400 PLUS CYCLOSPORINE (P920031/S003)Dade Behring, Inc.2002-07-24
COBAS INTEGRA CYCLOSPORINE (P920031/S002)Dade Behring, Inc.2002-02-26
EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY (P920031/S001)Dade Behring, Inc.2000-08-11
EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY (P920031)Dade Behring, Inc.1996-10-02